Jonathan Katz - Concepedia

Author

Jonathan Katz

Also Known As

J Katz, Jonathan Katz, Jonathan S Katz, Jonathan S. Katz, Jonathan Seth Katz, Karen Zakalik, Katz, Jonathan, Katz, Jonathan S., Richard S Bedlack

152

Publications

7.6K

Citations

H-Index

100

Concepts

All Affiliations

California Pacific Medical Center University of California, San Francisco Harvard University Stanford University University of California, Irvine

About

Jonathan Katz is an author at California Pacific Medical Center specializing in medicine, neurology, and neuropathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	2.1K
2	Public Health	3	3	387
3	Health Sciences	2	2	53
4	Social Sciences	1	1	15
5	Cardiothoracic Surgery	1	1	52

Jonathan Katz

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study James F. Howard, Kimiaki Utsugisawa, Michael Benatar, The Lancet Neurology Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade	2017	745
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, New England Journal of Medicine	2020	505
Immune‐mediated necrotizing myopathy associated with statins Phyllis Grable‐Esposito, Hans Katzberg, Steven A. Greenberg, Muscle & Nerve	2009	335
Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS) Rongzhen Zhang, Robert G. Miller, Ron Gascon, Journal of Neuroimmunology InflammationAmyotrophic Lateral SclerosisAutoimmune DiseaseMedicineImmunology	2008	319
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial Anne‐Marie Wills, Jane Hubbard, Eric A. Macklin, The Lancet NutritionPlacebo-controlled Phase 2Amyotrophic Lateral SclerosisClinical NutritionDietary Intake	2014	261
Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome David Saperstein, Anthony A. Amato, Gil I. Wolfe, Muscle & Nerve	1999	255
Whole-Genome Analysis of Sporadic Amyotrophic Lateral Sclerosis Travis Dunckley, Matthew J. Huentelman, David W. Craig, New England Journal of Medicine	2007	237
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Annals of Neurology	2009	233
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, The Lancet Neurology	2019	216
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study James F. Howard, Saskia Bresch, Angela Genge, The Lancet Neurology MedicineSurgeryClinical TrialsGeneralised Myasthenia Gravis	2023	213

Page 1